Fatemeh Koohi
Biographic Data
| ID | 7753692 |
|---|---|
| NAME | Fatemeh Koohi |
| GIVEN NAMES | Fatemeh |
| FAMILY NAME | Koohi |
| SIGNATURE | KOOHI F |
| AFFILIATIONS | Research Institute for Endocrine Sciences |
| ORCID | 0000-0003-1326-8594 |
| VERIFIED | Yes |
| TOTAL WORKS | 4 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 4 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2021 |
| LATEST PUBLICATION YEAR | 2023 |
| H-INDEX | 0 |
The association between fasting plasma glucose variability and incident eGFR decline
Higher FPG variability was associated with an increased risk of eGFR decline in the diabetic American population; however, this unfavorable impact was found only among the non-diabetic Iranian population
The trend of 10-year cardiovascular risk among diabetic and non-diabetic participants in Tehran Lipid and glucose study
The CVD risk and most CVD risk factors improved in individuals with and without diabetes in the past two decades; however, they have not reached the targets yet. So, more stringent lifestyle modifications and treatment strategies are needed, especially for primary prevention in the general population
Validation of the Framingham hypertension risk score in a middle eastern population
The revised Framingham hypertension risk score can be used as a screening tool in public health and clinical practice to facilitate the targeting of preventive interventions in high-risk Middle Eastern people
Development and validation of a knowledge, attitude, and practice questionnaire regarding cardiovascular diseases in an Iranian general population
Results provided evidence of the validity of the CVD-KAP29 for KAP studies for cardiovascular diseases in the general population
No prominent works on this page.
Validation of the Framingham hypertension risk score in a middle eastern population
The revised Framingham hypertension risk score can be used as a screening tool in public health and clinical practice to facilitate the targeting of preventive interventions in high-risk Middle Eastern people
Development and validation of a knowledge, attitude, and practice questionnaire regarding cardiovascular diseases in an Iranian general population
Results provided evidence of the validity of the CVD-KAP29 for KAP studies for cardiovascular diseases in the general population
The trend of 10-year cardiovascular risk among diabetic and non-diabetic participants in Tehran Lipid and glucose study
The CVD risk and most CVD risk factors improved in individuals with and without diabetes in the past two decades; however, they have not reached the targets yet. So, more stringent lifestyle modifications and treatment strategies are needed, especially for primary prevention in the general population
The association between fasting plasma glucose variability and incident eGFR decline
Higher FPG variability was associated with an increased risk of eGFR decline in the diabetic American population; however, this unfavorable impact was found only among the non-diabetic Iranian population
Medicine (4 works) · Biostatistics (3 works) · Internal Medicine (3 works) · Demography (2 works) · Demography (2 works) · Diabetes, Cardiovascular Risks, and Lipoproteins (2 works) · Disease (2 works) · Environmental health (2 works) · Epidemiology (2 works) · Framingham Risk Score (2 works)